Skip to main content
logo
Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium flag Belgium · Delayed Price · Currency is EUR
4.400
-0.020 (-0.45%)
Aug 31, 2026, 3:07 PM CET

Hyloris Pharmaceuticals Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
123192183357311447
Market Cap Growth
-32.52%4.59%-48.71%14.84%-30.44%82.10%
Enterprise Value
111174157319260402
Last Close Price
4.406.846.5412.7511.6017.30

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
15.5224.1218.7694.97130.24144.35
PB Ratio
4.657.235.709.145.779.30
P/TBV Ratio
5.338.286.0310.135.979.67

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
13.9921.9216.0984.88108.83129.77

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.060.060.060.050.020.18
Net Debt / Equity Ratio
-0.46-0.46-0.68-0.73-0.80-0.87
Net Debt / EBITDA Ratio
1.521.523.501.833.774.06
Net Debt / FCF Ratio
1.741.743.022.193.283.68
Asset Turnover
0.210.210.220.070.040.05
Quick Ratio
3.763.764.045.068.323.53
Current Ratio
3.893.894.155.228.633.60
Return on Equity (ROE)
-21.61%-21.61%-17.81%-33.08%-23.35%-21.62%
Return on Assets (ROA)
-13.63%-13.63%-8.94%-18.27%-11.58%-9.73%
Return on Capital Employed (ROCE)
-28.90%-28.90%-18.60%-38.70%-20.90%-21.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-5.14%-3.31%-3.46%-4.31%-3.83%-2.59%
FCF Yield
-5.68%-3.65%-3.94%-3.67%-4.22%-2.54%
Buyback Yield / Dilution
----2.95%-5.29%-18.40%